This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Fundacion Para La Investigacion Medica Aplicada, Modernatx, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 
1 out of 247 
Years Active: 2022-2025
Title: The Innovations of Antonio Fontanellas Roma
Introduction
Antonio Fontanellas Roma is a notable inventor based in Pamplona, Spain, recognized for his contributions to the field of medical research. With a total of two patents to his name, he has made significant strides in developing therapies for conditions such as Acute Intermittent Porphyria (AIP).
Latest Patents
His latest inventions center around mRNA therapy for the treatment of AIP. The first patent, titled "Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria," focuses on utilizing mRNAs that encode human porphobilinogen deaminase (PBGD) and its functional variants. These mRNAs are designed for in vivo administration, preferably encapsulated in lipid nanoparticles for effective delivery to target cells and tissues. This innovative approach not only aims to enhance PBGD expression levels but also seeks to reduce harmful metabolites associated with deficient PBGD activity, such as porphobilinogen and aminolevulinate.
In addition to this, he has also patented "Human porphobilinogen deaminase derived proteins and polynucleotides and uses thereof," which outlines the use of these proteins and their polynucleotides in therapeutic applications. This work underscores his commitment to finding solutions for medical conditions that remain challenging to treat.
Career Highlights
Throughout his career, Antonio has been associated with key organizations such as Fundación Para La Investigación Médica Aplicada and Modernatx, Inc. His work in these institutions has contributed greatly to advancing research in genetic therapies, particularly in the area of rare diseases.
Collaborations
Antonio has worked alongside esteemed colleagues in the field, including Pedro Berraondo Lopez and Irantzu Serrano Mendioroz. These collaborations have not only enriched his research but also fostered a culture of innovation that drives the team towards groundbreaking discoveries.
Conclusion
Antonio Fontanellas Roma stands out as a prominent figure in the field of medical innovation. His contributions, particularly in developing mRNA therapies, highlight the potential for scientific advancements in treating rare genetic disorders. With his ongoing work and collaborations, he continues to push the boundaries of what is possible in the realm of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile